| EPB41L4A-AS2 | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | 30971290 | 2019 |
| EPB41L4A-AS2 | non small cell lung cancer | qPCR, Western blot, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30249102 | 2018 |
| EPB41L4A-AS2 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31645082 | 2019 |
| EPB41L4A-AS2 | head and neck squamous cell carcinoma | RNA-seq, Microarray, qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29490660 | 2018 |
| EPB41L4A-AS2 | breast cancer | qPCR, Flow cytometry assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26980733 | 2016 |
| EPB41L4A-AS2 | Nasopharyngeal cancer | qRT-PCR;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 34131399 | 2021 |